Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1617, 2007-01, pp. : 16-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
No benefit, possible harm with GIK infusion for STEMI
Reactions Weekly, Vol. 1, Iss. 1181, 2007-01 ,pp. :
Access to resources
Recommend
Bivalirudin brings benefit to treatment of STEMI
Inpharma, Vol. 1, Iss. 1661, 2008-01 ,pp. :
BRAVE researchers say abciximab of no benefit in PCI for STEMI
Inpharma, Vol. 1, Iss. 1632, 2008-01 ,pp. :
Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 2, Iss. 1, 2015-01 ,pp. :
Hormone therapy and Alzheimer’s disease: benefit or harm?
Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. :